Iradimed (IRMD) Operating Income (2013 - 2026)

Iradimed (IRMD) has 14 years of Operating Income data on file, last reported at $7.2 million in Q1 2026.

• Operating Income for Q1 2026 came in at $7.2 million, up 33.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.8 million (down 65.73% YoY), and the FY2025 annual result was $6.0 million, down 72.88% from the prior year.
• Operating Income advanced to $7.2 million in Q1 2026 per IRMD's latest filing, from -$13.1 million in the prior quarter.
• Over five years, Operating Income peaked at $7.2 million in Q1 2026 and troughed at -$13.1 million in Q4 2025.
• A 5-year average of $4.2 million and a median of $5.2 million in 2023 frame the typical range for Operating Income.
• The sharpest annual moves came in 2022 and 2025: Operating Income jumped 125.93% in 2022, then tumbled 325.79% in 2025.
• A 5-year view of Operating Income shows it stood at $4.3 million in 2022, then gained by 21.3% to $5.2 million in 2023, then increased by 12.42% to $5.8 million in 2024, then plunged by 325.79% to -$13.1 million in 2025, then surged by 155.26% to $7.2 million in 2026.
• Business Quant data shows IRMD's Operating Income at $7.2 million in Q1 2026, -$13.1 million in Q4 2025, and $6.8 million in Q3 2025.